Zhengye Biotechnology logo
Zhengye Biotechnology
ZYBT | NASDAQ
Chart Builder DCF Calculator
$1.43
-$0.07 (-4.67%)
At close: Nov 16, 2026, 4:00 PM ET
$1.53
+$0.10 (+6.99%)
Pre-market: Nov 17, 2026, 4:00 AM ET

Zhengye Biotechnology Balance Sheet

Balance sheet explained
Fiscal Quarter
Period Ending
Q4 2025
Dec 31, 2025
Q3 2025
Sep 30, 2025
Q2 2025
Jun 30, 2025
Q4 2024
Dec 31, 2024
Q2 2024
Jun 30, 2024
Q4 2023
Dec 31, 2023
Q2 2023
Jun 30, 2023
Q4 2022
Dec 31, 2022
50.33M 50.33M 45.61M 18.6M 7.19M 15.07M 23.53M 9.75M
1.56M 1.56M 2.02M 1.43M 1.33M 1.22M – –
– – – – – – – –
7.01M 7.01M 16.98M 26.75M 18.92M 6.5M 4.21M 2.23M
18.49M 18.49M 87.91M 88.52M 91.65M 99.42M 124M 134.25M
39.17M 39.17M 53.55M 58.22M 65.19M 58.3M 53.98M 55.42M
6.78M 11.5M 2K 2K 15.71M 24.03M 12.81M 12.46M
137.42M 137.42M 201.45M 177.57M 189.73M 205.59M 216.92M 214.31M
237.28M 237.28M 246.7M 255.16M 254.34M 271.5M 274.9M 283.67M
54.76M 54.76M 23.17M 22.78M 24.62M 16.3M 17.81M 19.46M
299.05M 299.05M 303.18M 315.68M 297.88M 294.3M 296.91M 305.37M
436.47M 436.47M 504.63M 493.25M 487.61M 499.89M 513.83M 519.67M
44.01M 44.01M 42.8M 42.96M 41.64M 45.66M 48.95M 79.28M
4.83M – 6M 3.69M 3.22M 3.99M 4.64M 4.7M
65.8M 65.8M 81.06M 81.63M 87.39M 79.86M 79.86M 54.89M
397K 9.91M 929K 3.28M 215K – – –
120.48M 120.48M 134.84M 135.91M 137.43M 150.23M 177.42M 152.23M
8.85M 8.85M 4.7M 4.8M – 9.99M 9.99M 9.99M
– 104K – – 393K 393K 590K 590K
9.28M 9.28M 4.7M 4.8M 393K 10.38M 10.58M 10.58M
129.76M 129.76M 139.54M 140.71M 137.82M 160.62M 188M 162.81M
75.08M 75.08M 85.76M 86.43M 87.39M 89.85M 89.85M 64.88M
306.72M 306.72M n/a n/a n/a n/a n/a n/a
6.47 6.47 n/a n/a n/a n/a n/a n/a
8K 8K 8K 8K 8K 8K 8K 8K
-21.63M 11.01M 26.48M 48.15M 47.19M 38.38M 30.85M 65.77M
30.72M -1.93M 31.68M 32.65M 31.31M 31.31M 27.57M 27.57M
249.85M 249.85M 298.92M 283.96M 281.66M 272.85M 261.57M 296.5M
1.56M 1.56M 2.02M 1.43M 1.33M 1.22M – –

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.